Aluminum Oxide (Sapphire)

An oxide of aluminum, occurring in nature as various minerals such as bauxite, corundum, etc. It is used as an adsorbent, desiccating agent, and catalyst, and in the manufacture of dental cements and refractories.

Also Known As:

Networked: 524 relevant articles (13 outcomes, 102 trials/studies)

Relationship Network

Bio-Agent Context: Research Results

Experts

1.	Chuang, Lee-Ming: 7 articles (01/2015 - 04/2008)
2.	Chiu, Yen-Feng: 7 articles (01/2015 - 12/2006)
3.	Quertermous, Thomas: 6 articles (01/2015 - 03/2005)
4.	Kim, Young-Hoo: 6 articles (11/2013 - 09/2009)
5.	Kim, Hee Joong: 5 articles (01/2013 - 03/2005)
6.	Yoo, Jeong Joon: 5 articles (01/2013 - 03/2005)
7.	Ho, Low-Tone: 5 articles (07/2012 - 02/2006)
8.	Capello, William N: 5 articles (02/2012 - 12/2002)
9.	Kyotani, Tomohiro: 5 articles (07/2006 - 03/2005)
10.	Hung, Yi-Jen: 4 articles (01/2015 - 12/2006)

Related Diseases

1.	Endometriosis (Adenomyosis) 03/01/1991 - "We confirmed that contact irradiation with a cone-shaped sapphire probe provides adequate incision and lysis at lower power levels, and that this method is an effective treatment for ovarian endometriosis." 06/01/1990 - "We confirmed that contact irradiation with a cone-shaped sapphire probe provides an adequate incision and lysis at low power levels and that this method is an effective treatment for ovarian endometriomas." 06/01/1989 - "Thirty-eight patients had laparoscopic treatment of endometriosis by the use of the Nd:YAG laser, combined with a fiber-optic cable equipped with sapphire contact tips. " 03/01/1989 - "Laparoscopic laser treatment of endometriosis with the Nd:YAG sapphire probe." 03/01/1989 - "Laparoscopic surgery with the Nd:YAG laser generator and a sapphire probe was performed in 43 women for relief of pain and/or infertility associated with endometriosis and in two other women for treatment of an asymptomatic adnexal enlargement. "
2.	Neoplasms (Cancer) 09/01/2013 - "Similar results were obtained in a trial comparing FloSeal versus infrared-sapphire coagulator during open renal tumor enucleation. " 02/01/2001 - "A task exposure database (TED) was developed to facilitate data collation for construction of a task exposure matrix (TEM) for Healthwise, a series of studies on cancer and respiratory morbidity in the alumina and primary aluminium industry. " 12/16/2015 - "Herein, we report the fabrication of a novel nanomaterial, so-called anodic alumina nanotubes (AANTs) for proof-of-concept cancer therapy by targeting cell signaling networks. " 12/16/2015 - "Bioinert Anodic Alumina Nanotubes for Targeting of Endoplasmic Reticulum Stress and Autophagic Signaling: A Combinatorial Nanotube-Based Drug Delivery System for Enhancing Cancer Therapy." 08/26/2015 - "In Vitro Biocompatibility of Surface-Modified Porous Alumina Particles for HepG2 Tumor Cells: Toward Early Diagnosis and Targeted Treatment."
3.	Carotid Stenosis (Carotid Artery Stenosis) 09/01/2008 - "This review will summarize the results of randomized controlled trials (CAVATAS, WALLSTENT, SAPPHIRE, EVA-3S, SPACE, and CaRESS) as well as pivotal carotid registry studies (ARCHeR, BEACH, CAPTURE, CASES-PMS, CREATE, and CABernET) intended to evaluate the safety and efficacy of CEA and CAS in treatment of carotid stenosis. " 03/01/2015 - "The generalizability of trials like the SAPPHIRE or CREST to the Medicare population may be limited, underscoring the need to evaluate real-world effectiveness of carotid stenosis treatments." 03/01/2015 - "Indications and therapeutic management of carotid stenosis in high-risk patients: SAPPHIRE and beyond." 06/01/2007 - "Randomized trials like the SAPPHIRE trial have demonstrated that CAS is not inferior to carotid endarterectomy (CEA) in the treatment of carotid artery stenosis, and maybe even superior in high-risk symptomatic patients. " 07/01/2005 - "The SAPPHIRE trial compared the results of carotid endarteriectomy to those of carotid artery stenting with an emboli-protection device in patients with carotid artery stenosis and coexisting conditions that potentially increased the risk posed by endarteriectomy. "
4.	Stroke (Strokes) 05/01/2004 - "In 121 patients excluded on the basis of synchronous or immediate subsequent operations, who also would have been excluded from SAPPHIRE, the overall rates for stroke (1.65%; P =.69), death (1.65%; P =.09), and MI (0.83%; P =.71) were not significantly different from those in the study population. " 02/01/2011 - "Similarly, CAS was associated with 19%, 38%, 24%, and 48% increases in the intermediate to long-term outcomes of SAPPHIRE-like outcome, periprocedural death or stroke and ipsilateral stroke thereafter, death or any stroke, and any stroke, respectively. " 11/01/2006 - "In fact, 71% of patients in SAPPHIRE were asymptomatic in whom there was an average 6% 30-day death/stroke rate. " 07/01/2003 - "After similar blunting, all instruments were resharpened either with 10 strokes using an Arkansas fine-grit sharpening stone (AR), or with 7 strokes using a high-grit and -density aluminum oxide stone (CH). " 06/29/2010 - "All strokes to 30 days plus ipsilateral stroke between 31 and 360 days with CASES-PMS (5.4%) was similar to the rate seen with the SAPPHIRE trial stent cohort (4.9%). "
5.	Osteoarthritis 05/01/2012 - "Both the alumina-reduced and conventional surface acetabular cups can be used with confidence in primary THA for osteoarthritis, although longer-term studies are required to confirm these findings." 04/01/2001 - "The first 48 consecutive patients (50 hips) with osteoarthritis who had had primary total hip arthroplasty using the Cerafit Multicone stem and the Cerafit Triradius-M press-fit cup with alumina-alumina pairing (Ceraver Osteal, Paris, France) were followed-up for a mean of 2.3 years (2 to 2.5 years). " 10/01/1992 - "The use of a total hip prosthesis with an alumina ceramic head in THA is likely to lead to excellent results for patients with osteoarthrosis of the hip." 11/01/2006 - "Seventy patients with osteonecrosis of the femoral head (seventy-nine hips) received a cementless alumina-on-alumina bearing system and were directly matched to seventy-six patients with osteoarthritis of the hip (seventy-nine hips) who were managed with the same implant. " 09/01/2002 - "The aim of this work was to study the behavior of an inert porous alumina ceramic spacer used with a plate fixation for open-wedge tibial valgus osteotomy in patients with osteoarthritis of the knee and genu varum. "

Related Drugs and Biologics

1.	Polyethylene (Polythene)
2.	Cobalt
3.	Chromium
4.	Tacrolimus (Prograf)
5.	Ribavirin (Virazole)
6.	Interferons
7.	Proteins (Proteins, Gene)
8.	Gelatin
9.	Aluminum Oxide (Sapphire)
10.	Quartz

Related Therapies and Procedures

1.	Angioplasty (Angioplasty, Transluminal)
2.	Endarterectomy (Thromboendarterectomy)
3.	Stents
4.	Liver Transplantation
5.	Transplantation (Transplant Recipients)